from the white house? i think they are very reassuring. they know that formula shortage is of great concern. it is rather spotty, some areas of the country are more affected than others. i m in southern california and the great impact here was for some of the speciality formulas made by abbott, and those children have less options in terms of formula substitutions. what response have you seen to this shortage at the milk bank? you know, most families are not going to be looking to a milk bank to fill the gap if they are having trouble finding their normal baby formula. we encourage families to go look forformula, they can for formula, they can substitute other infant formulas and switch between brands until they find the supply is restored of their normalformula. babies that normal formula. babies that have normalformula. babies that have medical issues, premature babies, you babies, the families may be interested in reaching out to a milk bank to
of us in a team effort to make sure that there are no gaps in the actual supply. as you mentioned, the fda, we ve talked about the fda says it s doing its best to help do what it can to increase production. the fact that one abbott plant was shut down in february, i think leaves a lot of people scratching their heads that maybe one plant could lead to this. does it really all go back to that one plant? as with other industries, there were some supply chain challenges last fall, but they were mostly resolved by the time that this product recall started in february, and so it really is mostly attributable to abbott nutrition s recall of several powdered infant formulas. and so i think that leaves a pretty strong question of how did we let the market get this centralized. in the wic space there s only three companies that compete for contracts in the wic space. you really start to question is there really competition here. does that mean, really quickly, does that mean you may